ASAN FOUNDATION
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
A Study About Association Between Microbiome, Metabolome and Clinical Characteristics in COPD Patients
- Conditions
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT06101459
HCT With PTCy in Higher-risk MDS
- Conditions
- Interventions
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 113
- Registration Number
- NCT06098313
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
CyFluATG in Lower Risk MDS
- Conditions
- Interventions
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT06098326
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 850
- Registration Number
- NCT06086665
- Locations
- 🇰🇷
Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
- First Posted Date
- 2023-10-03
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT06064864
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
- First Posted Date
- 2023-09-22
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 86
- Registration Number
- NCT06051253
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
- Conditions
- Interventions
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 540
- Registration Number
- NCT06027307
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Yonsei University Medical Center, Seoul, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
Asan Aorta and Peripheral Registry
- Conditions
- First Posted Date
- 2023-09-05
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 6000
- Registration Number
- NCT06022653
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
The Effect of ERAS on Pancreaticoduodenectomy (v2.0)
- Conditions
- Interventions
- First Posted Date
- 2023-08-24
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 334
- Registration Number
- NCT06009224
- Locations
- 🇰🇷
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Atezolizumab Plus Bevacizumab Alone or Combined With External Beam Radiotherapy for HCC With Macrovascular Invasion
- First Posted Date
- 2023-08-15
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 138
- Registration Number
- NCT05992220
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of